AU2001253079A1 - Methods, compositions and kits for the detection and monitoring of breast cancer - Google Patents

Methods, compositions and kits for the detection and monitoring of breast cancer

Info

Publication number
AU2001253079A1
AU2001253079A1 AU2001253079A AU5307901A AU2001253079A1 AU 2001253079 A1 AU2001253079 A1 AU 2001253079A1 AU 2001253079 A AU2001253079 A AU 2001253079A AU 5307901 A AU5307901 A AU 5307901A AU 2001253079 A1 AU2001253079 A1 AU 2001253079A1
Authority
AU
Australia
Prior art keywords
compositions
breast cancer
protein
methods
kits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253079A
Inventor
Davin C. Dillon
Raymond L. Houghton
David Alan Molesh
David H Persing
Jiangchun Xu
Barbara Zehentner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001253079A1 publication Critical patent/AU2001253079A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Abstract

Compositions and methods for the therapy and diagnosis of cancer, such as breast cancer, are disclosed. Compositions may comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast tumor protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as breast cancer. Diagnostic methods based on detecting a breast tumor protein, or mRNA encoding such a protein, in a sample are also provided.
AU2001253079A 2000-04-03 2001-04-02 Methods, compositions and kits for the detection and monitoring of breast cancer Abandoned AU2001253079A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US19424100P 2000-04-03 2000-04-03
US60/194,241 2000-04-03
US21986200P 2000-07-20 2000-07-20
US60/219,862 2000-07-20
US22130000P 2000-07-27 2000-07-27
US60/221,300 2000-07-27
US25659200P 2000-12-18 2000-12-18
US60/256,592 2000-12-18
PCT/US2001/010631 WO2001075171A2 (en) 2000-04-03 2001-04-02 Methods, compositions and kits for the detection and monitoring of breast cancer

Publications (1)

Publication Number Publication Date
AU2001253079A1 true AU2001253079A1 (en) 2001-10-15

Family

ID=27498025

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253079A Abandoned AU2001253079A1 (en) 2000-04-03 2001-04-02 Methods, compositions and kits for the detection and monitoring of breast cancer

Country Status (9)

Country Link
US (1) US20020009738A1 (en)
EP (1) EP1272668B1 (en)
JP (1) JP2004505611A (en)
AT (1) ATE353974T1 (en)
AU (1) AU2001253079A1 (en)
CA (1) CA2404978A1 (en)
DE (1) DE60126592T2 (en)
ES (1) ES2281416T3 (en)
WO (1) WO2001075171A2 (en)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030125536A1 (en) * 1996-01-11 2003-07-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6656480B2 (en) * 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US20030044859A1 (en) * 1996-08-19 2003-03-06 Henslee Jerry G. Reagents and methods useful for detecting diseases of the breast
US8034920B2 (en) 1997-10-31 2011-10-11 Abbott Laboratories Nucleic acid primers and probes for detecting breast cells
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6692952B1 (en) * 1999-11-10 2004-02-17 Massachusetts Institute Of Technology Cell analysis and sorting apparatus for manipulation of cells
WO2001035811A2 (en) * 1999-11-16 2001-05-25 Eos Biotechnology, Inc. Methods of diagnosing and determining prognosis of breast cancer
AU4903101A (en) * 1999-11-30 2001-07-09 Cornell Research Foundation Inc. Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
WO2001040269A2 (en) * 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
WO2001098339A2 (en) * 2000-06-22 2001-12-27 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US6924358B2 (en) * 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
EP1569510B1 (en) 2002-09-27 2011-11-02 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
CN1230531C (en) * 2002-12-09 2005-12-07 清华大学 Method and kit for separating cell particle from sample
CN1223680C (en) * 2002-12-10 2005-10-19 清华大学 Method and kit for amplifying nucleic acid of target cell or virus
WO2004079014A2 (en) * 2003-03-04 2004-09-16 Arcturus Bioscience, Inc. Signatures of er status in breast cancer
EP1454994A1 (en) * 2003-03-07 2004-09-08 Université de la Méditerranée Standardized and optimized real-time quantitative reverse transcriptase polymerase chain reaction method for detection of MRD in leukemia
ATE420976T1 (en) * 2003-05-01 2009-01-15 Veridex Llc INTRAOPERATIVE LYMPH NODE TEST
US7267950B2 (en) * 2003-05-01 2007-09-11 Veridex, Lcc Rapid extraction of RNA from cells and tissues
US20050014168A1 (en) * 2003-06-03 2005-01-20 Arcturus Bioscience, Inc. 3' biased microarrays
US20070160503A1 (en) * 2003-06-13 2007-07-12 Palaniappan Sethu Microfluidic systems for size based removal of red blood cells and platelets from blood
US20050100933A1 (en) * 2003-06-18 2005-05-12 Arcturus Bioscience, Inc. Breast cancer survival and recurrence
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20050112622A1 (en) 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
WO2005017539A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Imaging pathology
CN101142314A (en) * 2004-03-03 2008-03-12 综合医院公司 Magnetic device for isolation of cells and biomolecules in a microfluidic environment
US7374927B2 (en) * 2004-05-03 2008-05-20 Affymetrix, Inc. Methods of analysis of degraded nucleic acid samples
CA2569502A1 (en) * 2004-06-04 2005-12-15 Veridex Llc Diagnosing or predicting the course of breast cancer
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
US20060051796A1 (en) * 2004-09-09 2006-03-09 Inga Boell Real time PCR with the addition of pyrophosphatase
EP1805325A1 (en) * 2004-10-28 2007-07-11 Abbott Laboratories Nucleic acid primers and probes for detecting breast cells
FR2878254B1 (en) * 2004-11-22 2010-08-20 Bio Rad Pasteur COMPOSITION FOR AMPLIFICATION OF NUCLEIC ACIDS
US20070026415A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026414A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US20070026417A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026416A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070059680A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for cell enrichment
US20090181421A1 (en) * 2005-07-29 2009-07-16 Ravi Kapur Diagnosis of fetal abnormalities using nucleated red blood cells
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070059774A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Kits for Prenatal Testing
US20070059781A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for size based separation and analysis
DE102006021257A1 (en) * 2006-04-28 2007-11-08 Eberhard-Karls-Universität Tübingen Universitätsklinikum Detection of transgenic DNA (t DNA)
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US20080070792A1 (en) * 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
US20080050739A1 (en) * 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
DE102008031699A1 (en) * 2008-07-04 2010-01-14 Protagen Ag Marker sequences for prostate inflammatory diseases, prostate cancer and their use
WO2010010951A1 (en) * 2008-07-24 2010-01-28 Kuroda Masahiko Method for detection of expression of indicator mrna acting as indicator for endometriosis-related diseases, and probe for use in the method
EP3378951B1 (en) 2008-09-20 2020-05-13 The Board of Trustees of the Leland Stanford Junior University Noninvasive diagnosis of aneuploidy by sequencing
WO2011024157A1 (en) * 2009-08-23 2011-03-03 Rosetta Genomics Ltd. Nucleic acid sequences related to cancer
US8187979B2 (en) * 2009-12-23 2012-05-29 Varian Semiconductor Equipment Associates, Inc. Workpiece patterning with plasma sheath modulation
KR101472789B1 (en) * 2012-05-10 2014-12-15 한국수력원자력 주식회사 Detection Method of Sensitive Genes for Low-Dose-Rate Radiation and Genes Detected by This Method
KR101445560B1 (en) 2012-05-10 2014-09-29 한국수력원자력 주식회사 Detection Method of Sensitive Genes for Low-Dose-Rate Radiation and Genes Detected by This Method
WO2014145620A2 (en) * 2013-03-15 2014-09-18 The Broad Institute, Inc. Novel hybridization probes and uses thereof
EP3272880B1 (en) * 2013-03-15 2020-11-25 Fundació Institut de Recerca Biomèdica (IRB Barcelona) Method for the diagnosis, prognosis and treatment of metastatic cancer
KR20170093182A (en) 2014-12-11 2017-08-14 인바이오모션 에스.엘. Binding members for human c-maf
CN107338290A (en) * 2017-06-26 2017-11-10 安徽普元生物科技股份有限公司 Human mammaglobin mRNA kit for detecting nucleic acid（PCR fluorescence probe methods）

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
AU3895597A (en) * 1996-07-26 1998-02-20 Genzyme Corporation Whole cell assay
DE19736715A1 (en) * 1996-08-17 1998-02-19 Invitek Gmbh Reagent for tumour diagnosis
JP2001505428A (en) * 1996-12-06 2001-04-24 ニールズ パリスガード Detection of chromosomal abnormalities
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
DE19813839A1 (en) * 1998-03-20 1999-09-23 Metagen Gesellschaft Fuer Genomforschung Mbh Human nucleic acid sequences and protein products from tumor breast tissue, useful for breast cancer therapy

Also Published As

Publication number Publication date
ES2281416T3 (en) 2007-10-01
WO2001075171B1 (en) 2003-02-06
CA2404978A1 (en) 2001-10-11
WO2001075171A2 (en) 2001-10-11
US20020009738A1 (en) 2002-01-24
EP1272668A2 (en) 2003-01-08
ATE353974T1 (en) 2007-03-15
WO2001075171A3 (en) 2002-08-08
EP1272668B1 (en) 2007-02-14
DE60126592T2 (en) 2007-11-22
JP2004505611A (en) 2004-02-26
DE60126592D1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
MXPA02000192A (en) Compositions and methods for the therapy and diagnosis of lung cancer.
WO2001040269A3 (en) Compositions and methods for therapy and diagnosis of breast cancer
WO2000060076A3 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
WO2001096388A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2001096390A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2000004149A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
WO2001025272A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
WO2001034802A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2001079286A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2000060077A3 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
WO2002083070A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO2000037643A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO2001073027A3 (en) Compositions and methods for therapy and diagnosis of colon cancer
WO2001072295A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2000052165A3 (en) Compositions and methods for breast cancer therapy and diagnosis
WO2001049716A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO2000078960A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2001057207A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2001051513A3 (en) Ovarian tumor-associated sequences
WO2001070976A3 (en) Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer
WO2001090152A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2002002623A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2001073031A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2001096389A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer